A Combination of Xanthohumol and Ursolic Acid in the Diet Leads to Synergistic Inhibition of Prostate Cancer Progression
Molecular Carcinogenesis · 2026
DOI: 10.1002/mc.70087 ↗At a glance
Journal article in Molecular Carcinogenesis, 2026. Written by Rachel Clark and 6 co-authors. Institution: Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA. Major MEDLINE topics: Triterpenes, Prostatic Neoplasms, Propiophenones, Flavonoids. Cited 2 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (original language)
Prostate cancer (PCa) is the second most common cancer and second leading cause of cancer death for American men. Chemoprevention by using phytochemicals offers a promising approach to improve outcomes due to their ability to act on cancer cell metabolism and growth while maintaining low toxicity profiles. The goal of this study was to assess the combination of xanthohumol (XAN) and ursolic acid (UA) given in the diet for synergistic efficacy against PCa progression and identify potential mechanisms of action. PCa cells were treated with the combination to evaluate cell survival and colony formation. Two mouse models of PCa were used to evaluate tolerability and efficacy of dietary administration of the combination and to further understand mechanism(s) of action. The combination of XAN + UA reduced PCa cell survival and colony formation. The combination given in the diet significantly and synergistically inhibited growth of HMVP2 PCa allograft tumors and also inhibited PCa progression in HiMyc mice. Mechanistically, inhibition of polyamine synthesis and epithelial‐to‐mesenchymal transition contributed to the inhibition of HMVP2 allograft tumor growth, while the inhibition of PCa progression in HiMyc mice was associated with activation of the unfolded protein response pathway and apoptosis. Further studies in cultured PCa cells revealed additional effects of the combination on several oncogenic signaling pathways (e.g, phospho‐STAT3) and cell cycle regulatory proteins (e.g, cyclin D1, phospho‐Rb).
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA.
- Department of Nutritional Sciences, The University of Texas at Austin, Austin, Texas, USA.
- Dell Medical School, Dell Pediatric Research Institute, The University of Texas at Austin, Austin, Texas, USA.
- Center for Molecular Carcinogenesis and Toxicology, The University of Texas at Austin, Austin, Texas, USA.
Funding
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Cite
APA
Clark, R., Saha, A., Lavender Hackman, G., Friedman, C. A., Gorgoglione, R., Tiziani, S., & DiGiovanni, J. (2026). A Combination of Xanthohumol and Ursolic Acid in the Diet Leads to Synergistic Inhibition of Prostate Cancer Progression. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70087
Vancouver
Clark R, Saha A, Lavender Hackman G, Friedman CA, Gorgoglione R, Tiziani S, et al. A Combination of Xanthohumol and Ursolic Acid in the Diet Leads to Synergistic Inhibition of Prostate Cancer Progression. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70087
BibTeX
@article{Clark2026,
author = {Clark, Rachel and Saha, Achinto and Lavender Hackman, G and Friedman, Chelsea A and Gorgoglione, Ruggiero and Tiziani, Stefano and DiGiovanni, John},
title = {A Combination of Xanthohumol and Ursolic Acid in the Diet Leads to Synergistic Inhibition of Prostate Cancer Progression},
journal = {Molecular Carcinogenesis},
year = {2026},
doi = {10.1002/mc.70087}
}
EUVIMED